← FDA Drug Approvals (Drugs@FDA)

REPAGLINIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SUN PHARM INDS INC · Approved 2013-07-11

Drug application

FDA Application #

ANDA077571

Application type

Abbreviated New Drug Application (Generic)

Brand name

REPAGLINIDE

Generic name

Repaglinide

Active ingredients

REPAGLINIDE

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

SUN PHARM INDS INC

First approval

2013-07-11

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown